Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1837 | 96 | 0.3501 | 0.3242 | 0.0523 | 0.0687 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 682 | 97 | 0.5745 | 0.6805 | 0.1422 | 0.1572 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 5069 | 97 | 0.2705 | 0.2505 | 0.0191 | 0.0221 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 714 | 97 | 0.6059 | 0.6759 | 0.1359 | 0.1363 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 4191 | 97 | 0.1962 | 0.1926 | 0.0231 | 0.0248 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 4202 | 97 | 0.1967 | 0.1926 | 0.0231 | 0.0248 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1603 | 97 | 0.4912 | 0.3835 | 0.0605 | 0.0574 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 1603 | 97 | 1.1534 | 1.0853 | 0.0605 | 0.0619 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 642 | 98 | 0.5508 | 0.6679 | 0.1526 | 0.1517 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1062 | 98 | 0.5940 | 0.5287 | 0.0923 | 0.0889 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2902 | 98 | 0.1420 | 0.1658 | 0.0338 | 0.0359 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 1 | 250 | 98 | 0.1539 | 0.1255 | 0.3920 | 0.4181 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 788 | 98 | 0.5505 | 0.4894 | 0.1244 | 0.1367 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 2 | 519 | 99 | 0.4124 | 0.4579 | 0.1908 | 0.1782 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 6033 | 99 | 0.3228 | 0.3515 | 0.0164 | 0.0163 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3533 | 99 | 0.1739 | 0.1709 | 0.0280 | 0.0246 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1663 | 100 | 0.3143 | 0.3143 | 0.0601 | 0.0600 |
A-375 | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 3786 | 100 | 0.2005 | 0.1991 | 0.0264 | 0.0233 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 1.000 | 1.000 | uM | 72 | hr | 3 | 515 | 100 | 0.4075 | 0.5227 | 0.1942 | 0.1868 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 255 | 100 | 0.1569 | 0.2379 | 0.3922 | 0.3676 |
MZ7-mel | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1146 | 101 | 0.2101 | 0.1839 | 0.0881 | 0.0837 |
WM-115 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 1 | 2039 | 101 | 0.5557 | 0.4993 | 0.0495 | 0.0637 |
MMAC-SF | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 782 | 102 | 0.5208 | 0.5813 | 0.1304 | 0.1242 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 6696 | 102 | 0.3587 | 0.3515 | 0.0152 | 0.0163 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 898 | 102 | 0.4904 | 0.4387 | 0.1136 | 0.1238 |